Search Results - "Güven, Deniz"

Survivorship outcomes in patients treated with immune checkpoint inhibitors: a scoping review by Güven, Deniz Can, Thong, Melissa Sy, Arndt, Volker

“…Immune checkpoint inhibitors (ICIs) have become a central part of cancer care. However, the survivorship outcomes in patients treated with ICIs are…”
Get full text

Fusobacterium and colorectal carcinogenesis by Güven, Deniz Can, Dizdar, Omer

Get full text

Bi-weekly irinotecan is an effective and convenient regimen in the treatment of relapsed or refractory small cell lung cancer by Yılmaz, Feride, Yaşar, Serkan, Tatar, Ömer Denizhan, Yıldırım, Hasan Çağrı, Güven, Deniz Can, Akyıldız, Arif, Chalabiyev, Elvin, Aktaş, Burak Yasin, Arık, Zafer, Erman, Mustafa

“…Despite initial dramatic responses, metastatic small cell lung cancer (SCLC) invariably recurs. Irinotecan is one of the active agents for patients with…”
Get full text

COVID-19 Infection in Children with Leukemia: A Single-center Retrospective Study by Elif Güler Kazancı, Deniz Güven, Rana Yılmaz

“…Objective: Children were less likely than adults to develop severe illness from coronavirus disease-2019 (COVID-19) infection, whereas children with leukemia…”
Get full text

Assessment of abuse and related factors in older patients with cancer by Akagunduz, Baran, Altın, Zeynep, Atcı, Muhammed Mustafa, Ozer, Muhammet, Güven, Deniz Can, Çil, İbrahim, Özçiçek, Fatih, Demirtaş, Levent, Duzgun, Eren, Gunderci, Azad, Arslan, Yusuf

“…Background Older cancer patients are more likely to present with functional dependency, multiple comorbidities, polypharmacy, malnutrition, and cognitive…”
Get full text

Sonographic Measurements of Rectus Femoris Muscle Thickness Strongly Predict Neutropenia in Cancer Patients Receiving Chemotherapy by Güner, Gürkan, Özçakar, Levent, Baytar, Yusuf, Onur, Mehmet Ruhi, Demir, Metin, Aktaş, Burak Yasin, Aktepe, Oktay Halit, Güven, Deniz Can, Taban, Hakan, Yıldırım, Hasan Çağrı, Akın, Serkan, Aksoy, Sercan, Kara, Murat, Dizdar, Ömer

“…The objective of this study was to explore the possible association between low skeletal muscle mass (SMM)-assessed by computed tomography (CT) and ultrasound…”
Get full text

Clinical outcomes of cyclin-dependent kinase 4–6 (CDK 4–6) inhibitors in patients with male breast cancer: A multicenter study by Yıldırım, Hasan Çağrı, Mutlu, Emel, Chalabiyev, Elvin, Özen, Miraç, Keskinkılıç, Merve, Ön, Sercan, Çelebi, Abdussamet, Dursun, Bengü, Acar, Ömer, Kahraman, Seda, Aykan, Musa Barış, Kaman, Ömür, Doğan, Akif, Erdoğan, Atike Pınar, Melisa Celayir, Özde, Günenç, Damla, Güven, Deniz Can, Vedat Bayoğlu, İbrahim, Yavuzşen, Tuğba, Hacıbekiroğlu, İlhan, İnanç, Mevlüde, Kılıçkap, Saadettin, Yalçın, Şuayib, Aksoy, Sercan

“…Since breast cancer is less common in men than in women, data on the use of new therapeutic agents, including cyclin-dependent kinase 4–6 (CDK 4–6) inhibitors,…”
Get full text

The real-life efficacy and safety of osimertinib in pretreated advanced non-small cell lung cancer patients with T790M mutation: a Turkish Oncology Group Study by Hizal, Mutlu, Bilgin, Burak, Paksoy, Nail, Açıkgöz, Özgür, Sezer, Ahmet, Gürbüz, Mustafa, Ak, Naziye, Yücel, Şebnem, Ayhan, Murat, Erol, Cihan, Demirkıran, Aykut, Mandel, Nil Molinas, Shbair, Abdallah, Gökmen, İvo, Başoğlu, Tuğba, Paydaş, Semra, Demiray, Atike Gökçen, İriağaç, Yakup, Şakalar, Teoman, Zeynelgil, Esra, Tatlı, Ali Murat, Bahçeci, Aykut, Güven, Deniz Can, Caner, Burcu, Can, Alper, Gülmez, Ahmet, Karakaş, Yusuf, Yalçın, Bülent, Demirkazık, Ahmet, Bilici, Ahmet, Aydıner, Adnan, Yumuk, Perran Fulden, Şendur, Mehmet Ali Nahit

“…Introduction Osimertinib, an irreversible third-generation EGFR-TKI, is the standard of care for second-line treatment of T790M-mutant advanced NSCLC patients…”
Get full text

ETIOLOGY, DIAGNOSIS, AND MANAGEMENT OF CHILDHOOD MICROCEPHALY: A SINGLE-CENTER RETROSPECTIVE STUDY by Güven, Deniz, Ardıçlı, Didem, Sarıcı, Dilek

“…Background: Microcephaly is a condition that causes a reduction in brain volume as well as cognitive and motor impairments. It can be seen alone or in…”
Get full text

Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group by Ünal, Çağlar, Azizy, Abdulmunir, Karabulut, Senem, Taştekin, Didem, Akyıldız, Arif, Yaşar, Serkan, Yalçın, Şuayib, Çoban, Eyüp, Evrensel, Türkkan, Kalkan, Ziya, Oruç, Zeynep, Derin, Sümeyra, Turna, Zeynep Hande, Bayram, Doğan, Köş, Fahriye Tuğba, Şendur, Mehmet Ali Nihat, Sever, Nadiye, Ercelep, Özlem, Seyyar, Mustafa, Kefeli, Umut, Uygun, Kazım, Özçelik, Melike, Ön, Sercan, Şanlı, Ulus Ali, Canaslan, Kübra, Ünek, İlkay Tuba, Yücel, Kadriye Bir, Özdemir, Nuriye, Yazıcı, Ozan, Güzel, Halil Göksel, Salim, Derya Kıvrak, Göksu, Sema Sezgin, Tatlı, Ali Murat, Ordu, Çetin, Selvi, Oğuzhan, Sakin, Abdullah, Büyükbayram, Mehmet Emin, Dursun, Bengü, Ürün, Yüksel, Arak, Hacı, Ağdaş, Gözde, Uğraklı, Muzaffer, Hendem, Engin, Eryılmaz, Melek Karakurt, Bilgin, Burak, Topçu, Atakan, Şimşek, Melih, Büyükşimşek, Mahmut, Akay, Büşra, Erdal, Gülçin Şahingöz, Karataş, Fatih, Alan, Özkan, Çağlayan, Melek, Kahvecioğlu, Fatma Akdağ, Demirci, Ayşe, Paksoy, Nail, Çetin, Bülent, Gümüş, Mahmut, Ak, Naziye, Aydınalp, Yasemin, Paydaş, Semra, Güven, Deniz Can, Kılıçkap, Saadettin, Sağlam, Sezer

“…Abstract Introduction This study aims to report the efficacy and safety of capecitabine plus temozolomide (CAPTEM) across different lines of treatment in…”
Get full text

Comparison of PD-L1 and VISTA expression status in primary and recurrent/refractory tissue after (chemo)radiotherapy in head and neck cancer by Şener, Görkem Yazıcı, Sütcüoğlu, Osman, Öğüt, Betül, Güven, Deniz Can, Kavuncuoğlu, Altan, Özdemir, Nuriye, Özet, Ahmet, Aksoy, Sercan, Tezel, Yeşim Gaye Güler, Akyürek, Nalan, Yazıcı, Ozan

“…Background PD-L1 and VISTA are thought to play a role in escape from the immune system, tumor progression, and treatment response in tumoral tissue. The…”
Get full text

Does docetaxel matter in metastatic gastric cancer? FOLFOX versus FLOT regimens as first-line treatment by Gürler, Fatih, İlhan, Ayşegül, Güven, Deniz Can, Turhan, Okan, Kurt İnci, Bediz, Sütçüoğlu, Osman, Yildiz, Fatih, Arik, Zafer, Öksüzoğlu, Berna, Yalçin, Şuayib, Özdemir, Nuriye, Yazici, Ozan, Özet, Ahmet

“…We aimed to compare the efficacy and the safety of the FOLFOX and the FLOT regimens in metastatic gastric cancer (mGC) as first-line treatment. It was a…”
Get full text

Variation in the rate of diagnosis of childhood acute lymphoblastic leukemia in about to the COVID-19 Pandemic: a single-center study by Kazancı, Elif Güler, Üstündağ, Yasemin, Güven, Deniz

“…Background. Greaves delayed infection hypothesis states that acute lymphoblastic leukemia (ALL) in children develops in two critical steps, with the first step…”
Get full text

SMART syndrome: a case report by Bozkurt, Saliha, Toprak, Berna, Yıldırım, Hasan Çağrı, Parlak, Şafak, Güven, Deniz Can, Kertmen, Neyran, Oğuz, Kader Karlı, Dizdar, Ömer

“…Introduction Stroke-like migraine attacks after radiation therapy (SMART) syndrome, is a late complication of brain radiotherapy (1). Symptoms are commonly…”
Get full text

Evaluation of Anti-Mullerian Hormone Levels, Antral Follicle Counts, and Mean Ovarian Volumes in Chemotherapy-Induced Amenorrhea among Breast Cancer Patients: A Prospective Clinical Study by Ünal, Çağlar, Ordu, Çetin, Özmen, Tolga, İlgun, Ahmet Serkan, Çelebi, Filiz, Baysal, Bülent, Özkurt, Enver, Duymaz, Tomris, Erdoğan İyigün, Zeynep, Kurt, Sevgi, Öztürk, Mehmet Alper, Pilancı, Kezban Nur, Alço, Gül, Yararbaş, Kanay, Kayan Tapan, Tuba, Güven, Deniz Can, Soybir, Gürsel, Özmen, Vahit

“…Estradiol (E2), a follicle-stimulating hormone (FSH), AMH, and inhibin B levels, along with AFC and MOV, are used to determine ovarian reserve in…”
Get full text

Crizotinib efficacy and safety in patients with advanced NSCLC harboring MET alterations: A real-life data of Turkish Oncology Group by Gürbüz, Mustafa, Kiliçkap, Saadettin, Bilici, Ahmet, Karadurmuş, Nuri, Sezer, Ahmet, Şendur, Mehmet Ali Nahit, Paydaş, Semra, Artaç, Mehmet, Fulden Yumuk, Perran, Gürsoy, Pinar, Uysal, Mükremin, Şenol Coşkun, Hasan, Tatli, Ali Murat, Selçukbiricik, Fatih, Dişel, Umut, Köksoy, Elif Berna, Güven, Deniz Can, Uğrakli, Muzaffer, Akkuş, Erman, Yücel, Şebnem, Erol, Cihan, Karakaya, Serdar, Şakalar, Teoman, Khanmammadov, Nijat, Paksoy, Nail, Demirkazik, Ahmet

“…Crizotinib is a multikinase inhibitor, effective in non-small cell lung cancer (NSCLC) harboring mesenchymal-epidermal transition (MET) alterations. Although…”
Get full text

Seven-Year Single-Center Experience of the Efficacy and Safety of Ferric Carboxymaltose in Cancer Patients with Iron-Deficiency Anemia by Aktaş, Burak Yasin, Ata, Emine Büşra, Çeşmeci, Engin, Çakır, İbrahim Yahya, Coşkunpınar, Muharrem, Tahillioğlu, Yağmur, Güner, Gürkan, Güven, Deniz Can, Arık, Zafer, Kertmen, Neyran, Dizdar, Ömer, Yalçın, Şuayib, Aksoy, Sercan

“…Anemia remains an essential concern affecting the quality of life and the survival of cancer patients. Although there are different approaches to treating…”
Get full text

What is the Role of Mannose-Binding Lectin Gene Polymorphism in the Development of Acute Post-Streptococcal Glomerulonephritis? by Deniz Güven, Mustafa Bak, Erkin Serdaroğlu, Ferda Özkınay, Ayça Aykut

“…Objective: This study aims to determine the effects of the mannose-binding lectin (MBL) gene polymorphism on the clinical and laboratory findings, response to…”
Get full text

The percentage of ALK-positive cells and the efficacy of first-line alectinib in advanced non-small cell lung cancer: is it a novel factor for stratification? (Turkish Oncology Group Study) by Hizal, Mutlu, Bilgin, Burak, Paksoy, Nail, Atcı, Muhammed Mustafa, Kahraman, Seda, Kılıçkap, Saadettin, Güven, Deniz Can, Keskinkılıç, Merve, Ayhan, Murat, Eren, Önder, Mustafayev, Fatma Nihan Akkoç, Yaman, Şebnem, Bayram, Ertuğrul, Ertürk, İsmail, Özcan, Erkan, Korkmaz, Mustafa, Akagündüz, Baran, Erdem, Dilek, Telli, Tuğba Akın, Aksoy, Asude, Üskent, Necdet, Baytemür, Naziyet Köse, Gülmez, Ahmet, Aydın, Dinçer, Şakalar, Teoman, Arak, Hacı, Tatlı, Ali Murat, Ergün, Yakup, Ak, Naziye, Ünal, Çağlar, Özgün, Mehmet Alpaslan, Yalçın, Bülent, Öztop, İlhan, Algın, Efnan, Sakin, Abdullah, Aydıner, Adnan, Yumuk, Perran Fulden, Şendur, Mehmet Ali Nahit

“…Introduction Alectinib is an effective second-generation ALK tyrosine kinase inhibitor (TKI) used in the first-line treatment of patients with advanced…”
Get full text

Atezolizumab combined with chemotherapy in the first-line treatment of extensive-stage small cell lung cancer: a real-life data of the Turkish Oncology Group by Gürbüz, Mustafa, Kutlu, Yasin, Akkuş, Erman, Köksoy, Elif Berna, Köse, Naziyet, Öven, Bala Başak, Uluç, Başak Oyan, Demiray, Atike Gökçen, Erdem, Dilek, Demir, Bilgin, Turhal, Nazım Serdar, Üskent, Necdet, Akbaş, Sinem, Selçukbiricik, Fatih, İnal, Ali, Bilici, Ahmet, Ölmez, Ömer Fatih, Çabuk, Devrim, Ünal, Çağlar, Hızal, Mutlu, Şendur, Mehmet Ali Nahit, Korkmaz, Mustafa, Karadurmuş, Nuri, Ertürk, İsmail, Göksu, Sema Sezgin, Tatlı, Ali Murat, Güven, Deniz Can, Kılıçkap, Saadettin, Paksoy, Nail, Aydıner, Adnan, Çınkır, Havva Yeşil, Özkul, Özlem, Öztürk, Akın, Ballı, Sevinç, Kemal, Yasemin, Erdoğan, Atike Pınar, Er, Özlem, Yumuk, Perran Fulden, Demirkazık, Ahmet

“…Purpose Atezolizumab has been shown to be effective and safe in randomized trial in the first-line treatment of extensive-stage small cell lung cancer (SCLC)…”
Get full text